CytoHealth

Home
Malaysia
Kuala Lumpur
CytoHealth

Discovering the Transformative Power of
Regenerative Medicine with Evidence-based Solutions

MY CYTOHEALTH SDN BHD
[Reg. No. 202001033724 (1390045-T)]

My CytoHealth Sdn Bhd [Reg. No. 202001033724 (1390045-T)], founded in 2020, is one of the Malaysia leading bioprocessing company that places great emphasis on research and continuous development. CytoHealth strongly believes in facts, data, and evidence-based solutions; hence, we always deliver our best services and expertise in bioprocessing for regenerative medicine and immunotherapy. We partne

r with medical facilities, research institutions, and universities to advance the frontiers of knowledge and medical innovation in these fields. CytoHealth trusts in local development and we are dedicated to moving laboratory discoveries from lab scale to real-life applications. Know more about us: https://linktr.ee/cytohealth

24/05/2026

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝘂𝗺𝗺𝗶𝘁 𝗔𝘀𝗶𝗮 𝟮𝟬𝟮𝟲! ✨
Following an impactful three days from 20–22 May, CytoHealth was proud to be part of the summit, jointly organized by Qube Integrated Malaysia and Green Wellness Malaysia — bringing together healthcare professionals and key industries to explore the future of regional healthcare and wellness in Asia.

The summit highlighted a growing convergence across the landscape, driven by a collective commitment toward scientific advancement, technology, and evidence-driven innovation solutions.

During the event, our team was honored to share our 𝗽𝗮𝘁𝗲𝗻𝘁-𝗴𝗿𝗮𝗻𝘁𝗲𝗱 𝗲𝘅𝗼𝘀𝗼𝗺𝗲 𝗳𝗿𝗲𝗲𝘇𝗲-𝗱𝗿𝘆𝗶𝗻𝗴 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 with the Deputy Minister of Health Malaysia, Yang Berhormat Dato’ Hajjah Hanifah Hajar Taib. As a BioNexus Status company and one of the few Malaysian bioprocessing players on the exhibition floor, it was highly encouraging to witness the growing recognition of robust bioprocessing technologies as part of the broader healthcare conversation, bridging the gap between medical science and real-world healthcare applications. ✨

Thank you to the organizers, and to everyone who visited our booth, shared insights, and explored potential synergies with us.

𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿, 𝗹𝗲𝘁 𝘂𝘀 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝗯𝗲𝗻𝗰𝗵 𝘁𝗼 𝗯𝗲𝗱𝘀𝗶𝗱𝗲, 𝗱𝗿𝗶𝘃𝗲𝗻 𝗯𝘆 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗿𝗲𝗹𝗲𝘃𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝘀𝗰𝗮𝗹𝗮𝗯𝗹𝗲 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆. 💪

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿, 𝗖𝗼𝗻𝗻𝗲𝗰𝘁, 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲.

22/05/2026

𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝗶𝘁 𝗿𝗲𝗮𝗹𝗹𝘆 𝘁𝗮𝗸𝗲 𝘁𝗼 𝗯𝘂𝗶𝗹𝗱 𝗮 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗰𝗼𝗺𝗽𝗮𝗻𝘆?

After 5 years, our CEO 𝗗𝗿. 𝗟𝗶𝘆𝗶𝗻 𝗪𝗼𝗻𝗴, shares her reflections on what half a decade in regenerative medicine has truly taught us:

• Innovation is hard, but reproducibility is harder.
• Real sustainability comes from systems, not breakthroughs.
• The power of 1% improvements repeated daily can compound into long-term competitive advantage.
• Ecosystem-building matters just as much as company-building.

5 years of science translation. This is not just a milestone reflection. It is the operating philosophy behind CytoHealth.

𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: https://www.linkedin.com/feed/update/urn:li:activity:7463558940128092160

20/05/2026

Behind every healthcare advancement are years of scientific evaluation, validation, and refinement.

This International Clinical Trials Day, we recognize the importance of rigorous science, responsible development, and the continuous pursuit of evidence beyond the laboratory.

𝗙𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗟𝗶𝗳𝗲.
𝗪𝗶𝘁𝗵 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲-𝗕𝗮𝘀𝗲𝗱 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀.

11/05/2026

𝗞𝗶𝗰𝗸𝘀𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝗼𝘂𝗿 𝗳𝗶𝗿𝘀𝘁 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻 𝗼𝗳 𝟮𝟬𝟮𝟲! 🤩
CytoHealth is excited to exhibit at Health Summit Asia (HSA), the 26th SE-Asian Healthcare & Pharma Show, taking place from 20–22 May at the Kuala Lumpur Convention Centre (KLCC).

In collaboration with SEACare and the International Wellness Expo (IWE), the summit brings together the healthcare, medical, pharmaceutical, and wellness sectors to showcase the future transformation of healthcare.

Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟳𝗙𝟬𝟳, 𝗛𝗮𝗹𝗹 𝟳 to discover how CytoHealth’s proprietary technologies are translating regenerative medicine science into reproducible and evidence-driven healthcare applications through controlled bioprocessing systems.

We look forward to seeing you there!

03/05/2026

𝗡𝗼𝘁 𝗮𝗹𝗹 𝘀𝘁𝗲𝗺 𝗰𝗲𝗹𝗹𝘀 𝗮𝗿𝗲 𝗰𝗿𝗲𝗮𝘁𝗲𝗱 𝗲𝗾𝘂𝗮𝗹, 𝗶𝘁 𝗯𝗲𝗴𝗶𝗻𝘀 𝘂𝗽𝘀𝘁𝗿𝗲𝗮𝗺.
From sourcing to expansion, small variations in each step can lead to significant differences in outcomes. As cells scale, reproducibility becomes increasingly complex.

Because in biologics, consistency is not a feature.
It is a process and a critical aspect to pursue.

At CytoHealth, this is where our focus lies.

25/04/2026

Regenerative medicine is emerging as a key area within Malaysia’s healthcare travel landscape, requiring alignment across science, regulation, and clinical practice.

MHTC engaged key stakeholders in the regenerative medicine ecosystem, including Dr. Liyin Wong, Chief Executive Officer and Dr. Daniel Looi, Chief Scientific Officer of CytoHealth Group.

The discussion clarified Malaysia’s current position across regulatory frameworks, clinical guidelines, technical capabilities, and governance requirements related to stem cell applications. It also surfaced opportunities to strengthen education and awareness, supporting safer and more consistent practices within the regenerative medicine space.

Engagements like this help shape the conditions needed for responsible integration of regenerative medicine into the healthcare travel ecosystem, anchored in safety, readiness, and long-term credibility, in line with the direction of .

MHTC looks forward to continued collaboration with industry stakeholders to support the development of this emerging field.

Follow MHTC for more updates on our strategic engagements.

23/04/2026

𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝘄𝗼𝗿𝗸 𝗶𝘀 𝗻𝗼𝘁 𝗿𝗲𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 — 𝗶𝘁 𝗶𝘀 𝗮 𝗱𝗶𝘀𝗰𝗶𝗽𝗹𝗶𝗻𝗲 𝗼𝗳 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻.
At CytoHealth, every bioprocessing step is a testament to reproducibility and validation.

Today on World Laboratory Day, we shine a light on our team behind the glass. Their expertise and dedication to remind that the scientific breakthroughs aren't just one-off successes, but built on the rigor of daily discipline.

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺: https://www.linkedin.com/posts/cytohealth_regenerativemedicine-explorewithcytohealth-activity-7241653038224965632-u6vs

16/04/2026

Have you ever wondered: what happens after the paper? 🤔 The journey from research to commercialization is often missing roadmap. Too often, great ideas fails not due to the science, but due to an unclear translation path.

Yesterday at Taylor's University, during the seminar on 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗖𝗼-𝗰𝗿𝗲𝗮𝘁𝗶𝗼𝗻, our CSO, Dr. Daniel Looi, shared insights on bridging this "Gap", moving beyond knowledge generation toward meaningful clinical benefit.

A great idea should do more than end up in a journal. Beyond publication, for research to have a true clinical impact, we must focus on:

✅ Understanding unmet clinical needs.
✅ Building reproducible standards.
✅ Translating findings into practical applications.

It's time to move from discovery-driven narratives toward translation-focused outcomes. Together, let us continue to advance innovation from bench to bedside, driven by scientific relevance and scalable technology. 🔬

𝗧𝗵𝗶𝗻𝗸 𝗯𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗯𝗼𝘅.
𝗕𝘂𝗶𝗹𝗱 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮 𝗽𝗮𝗽𝗲𝗿.

14/04/2026

𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗥𝗮𝘆𝗮 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗖𝘆𝘁𝗼𝗛𝗲𝗮𝗹𝘁𝗵 𝗳𝗮𝗺𝗶𝗹𝘆 🍽️🥰
More than just a gathering, it was a moment to strengthen bonds, appreciate one another, and grow stronger together.

Selamat Hari Raya Aidilfitri.
May this spirit of togetherness continue beyond the celebration.

07/04/2026

𝗧𝗵𝗶𝘀 𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗮𝘆, 𝘄𝗲 𝘀𝘁𝗮𝗻𝗱 𝘄𝗶𝘁𝗵 𝘀𝗰𝗶𝗲𝗻𝗰𝗲.🔬
As regenerative medicine and advanced biologics continue to reshape healthcare, we join the global community in advocating for science-led solutions that define real progress.

Because the future of healthcare isn’t built on hype.
It’s built on science.

Address

Plaza Hamodal, Lot No. 15, Jalan 13/2, Section 13
Kuala Lumpur
46200

Website

https://mycytohealth.com/

Alerts

Be the first to know and let us send you an email when CytoHealth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CytoHealth:

Shortcuts

Want your business to be the top-listed Engineering Company in Kuala Lumpur?